Hanall Biopharma Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hanall Biopharma Company Limited with three other
companies in this sector in South Korea:
Wooridul Pharmaceutical Limited
sales of 79.89 billion Korean Won [US$75.02 million]
of which 100%
Binex Company Ltd
(78.03 billion Korean Won [US$73.27 million]
of which 83%
was Pharmaceutical), and
Dongsung Pharmaceutical Company Limited
(82.39 billion Korean Won [US$77.36 million]
of which 92%
was Pharmaceutical Segment).
Hanall Biopharma Company Limited reported sales of 84.23 billion Korean Won (US$79.09 million)
December of 2017.
a very small
increase of 1.6%
versus 2016, when the company's sales were 82.88 billion Korean Won.